Shares of Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the six analysts that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation, three have assigned a buy recommendation and one has assigned a strong buy recommendation to the company.
STVN has been the topic of several recent research reports. KeyCorp reduced their price target on Stevanato Group from $37.00 to $32.00 and set an “overweight” rating on the stock in a research note on Thursday, March 5th. Weiss Ratings lowered Stevanato Group from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, March 11th. Citigroup dropped their target price on shares of Stevanato Group from $32.00 to $26.00 and set a “buy” rating on the stock in a report on Thursday, March 5th. Jefferies Financial Group set a $17.50 target price on shares of Stevanato Group in a research report on Tuesday, February 10th. Finally, Wall Street Zen lowered shares of Stevanato Group from a “buy” rating to a “hold” rating in a research note on Saturday, February 14th.
Check Out Our Latest Report on STVN
Institutional Inflows and Outflows
Stevanato Group Stock Performance
NYSE:STVN opened at €15.45 on Friday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.26 and a current ratio of 1.76. Stevanato Group has a fifty-two week low of €13.91 and a fifty-two week high of €28.00. The firm has a market cap of $4.68 billion, a PE ratio of 26.63, a price-to-earnings-growth ratio of 1.37 and a beta of 0.57. The business has a 50 day moving average price of €16.82 and a 200-day moving average price of €21.28.
About Stevanato Group
Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.
Featured Stories
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
